Pharma news
Pharma
Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes. 12 March 2024
Pharma
WTO members failed to reach consensus on whether to expand patent waiver agreed in 2022 | Extended proposal would include tests and treatments for COVID-19. 7 March 2024
Pharma
Firm wishes to avoid ‘protracted litigation’ with confidential settlement | Counsel for GSK told Delaware judge in January that lawsuits are ‘way ahead of the science’. 29 February 2024
Biotech
DePuy Synthes tries to overturn a ruling over knee replacement device | Challenges the court's decision, including ownership disputes, interpretation of critical terms, and the granting of a permanent injunction. 27 February 2024
Pharma
Board determines that Nevro added subject matter to patent through amendment | Medtronic and Boston Scientific have successfully overturned 2019 decision rejecting opposition. 20 February 2024
Pharma
Judge says UK courts should depart from a European precedent following Brexit | MSD counsel says appeal had been granted due to courts' “ flip-flopping” on the precedent(s) set by the landmark cases Neurim and Santen. 15 February 2024
Pharma
US pharma firm has not admitted liability as part of agreement with Lipitor buyers following a long-running dispute over a cholesterol drug | Litigation against Sun Pharma’s Ranbaxy will continue. 15 February 2024
Americas
US Patent and Trademark Office publishes ‘clear’ guidance mandating AI-related patents to have ‘significant’ human involvement | Cites one hypothetical example relating to the development of a compound for treating cancer | Kathi Vidal: ‘patent system was developed to incentivise and protect human ingenuity’. 13 February 2024
Pharma
Appeals court sides with GSK unit in licensing dispute over ovarian cancer drug | Judges find fault with previous decision ordering the pharma firm to pay royalties on all sales of an ovarian cancer treatment. 13 February 2024
Americas
Senator criticises patent thickets and ‘monopolies’ ahead of senate hearing convened to interrogate CEOs | Sales of MSD’s blockbuster cancer treatment Keytruda rival McDonald’s annual revenue, says report. 8 February 2024